Abstract | CONCLUSION: OBJECTIVE: METHODS: Patients were randomized to either power-assisted partial turbinectomy or daily use of mometasone furoate nasal spray for 6 months. Evaluation by peak nasal inspiratory flow (PNIF) and grading of symptoms by use of visual analog scale was done after 3 and 6 months. Grading of symptoms was also done by use of a questionnaire approximately 30 months after the last visit. RESULTS: PNIF scores improved for all patients, although significantly only for patients on mometasone spray. Patients' self-reported symptoms decreased more for operated patients. Side effects were few and mild in both groups.
|
Authors | Tomas Norlander, Mats Lindén |
Journal | Acta oto-laryngologica
(Acta Otolaryngol)
Vol. 131
Issue 12
Pg. 1286-92
(Dec 2011)
ISSN: 1651-2251 [Electronic] England |
PMID | 21905959
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Nasal Sprays
- Pregnadienediols
- Mometasone Furoate
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents
(therapeutic use)
- Chronic Disease
- Female
- Humans
- Inspiratory Capacity
- Male
- Middle Aged
- Mometasone Furoate
- Mouth Breathing
- Multivariate Analysis
- Nasal Obstruction
(etiology, therapy)
- Nasal Sprays
- Pregnadienediols
(therapeutic use)
- Quality of Life
- Rhinitis
(complications, therapy)
- Severity of Illness Index
- Sinusitis
(complications, therapy)
- Smell
- Turbinates
(surgery)
- Young Adult
|